Delta Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Delta Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.3K	Hold	16,000	–	–	﹤0.01%	314
2026 Q2	$41.4K	Hold	16,000	–	–	﹤0.01%	290
2026 Q1	$49.1K	Hold	16,000	–	–	﹤0.01%	274
2025 Q4	$57K	Buy	16,000 +3,000	+23%	+$18.4K	﹤0.01%	251
2025 Q3	$116K	Buy	13,000 +1,000	+8%	+$10.1K	0.01%	191
2025 Q2	$111K	Buy	12,000 +1,000	+9%	+$8.54K	0.01%	188
2025 Q1	$94.4K	Buy	11,000 +9,000	+450%	+$85K	0.01%	195
2024 Q4	$21.5K	Buy	+2,000	New	+$15.4K	﹤0.01%	360

Other funds holding AVXL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Delta Asset Management's AVXL Position: Q3 2026 in Review

Delta Asset Management held its Anavex Life Sciences (AVXL) position steady in Q3 2026 at 16,000 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Delta Asset Management first reported a position in AVXL in Q4 2024 and has held it in 8 quarters since. The position peaked at $116K in Q3 2025. 126 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

Delta Asset Management held 16,000 shares of Anavex Life Sciences worth $32.3K as of Q3 2026.
Delta Asset Management left its Anavex Life Sciences share count unchanged in Q3 2026.
Anavex Life Sciences made up ﹤0.01% of Delta Asset Management's portfolio in Q3 2026, its #314 holding.
Delta Asset Management first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 8 quarters since.
Delta Asset Management's Anavex Life Sciences position peaked at $116K in Q3 2025.
126 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Delta Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.